本报记者李万晨曦 据了解，今年4月21日，*ST长药披露关于公司股票交易被实施退市风险警示和其他风险警示暨停牌的 公告，因公司2024年度期末净资产为负且连续三年扣非净利润为负值，2025年4月21日开市起停牌一 天，自2025年4月22日开市起复牌，复牌之日起深圳证券交易所对公司股票交易实施退市风险警示和其 他风险警示，公司证券简称由"长药控股"变更为"*ST长药"。 公告称，2025年5月6日，公司和临时管理人分别与产业投资人四川嘉道博文生态科技有限公司、十堰市 昊炜生物科技发展有限公司，财务投资人合肥当歌长弘创业投资合伙企业（有限合伙）、安徽宏业股权 投资基金有限公司、上海琉光东承企业管理咨询合伙企业（有限合伙）、大涵私募证券基金管理（深 圳）有限公司签署重整投资协议。 根据协议约定，以上市公司现有总股本3.50亿股为基数，按每10股转增15股的比例进行资本公积金转增 股本，共计可转增5.26亿股，转增价格2.42元/股。转增完成后，上市公司的总股本由3.50亿股增至8.76 亿股（最终转增的准确股票数量以中国证券登记结算有限责任公司深圳分公司实际登记确认的数量为 准）。 回溯预重整的进展，2025年1 ...

Core Viewpoint - China Zhongwang Holdings Limited, once known as the "Asian Aluminum King," announced its delisting from the Hong Kong Stock Exchange, with the last trading day set for April 12, 2023, marking a significant decline from its peak as a major player in the aluminum industry [2][3]. Company Overview - China Zhongwang was established in 1993 and is headquartered in Liaoyang, Liaoning Province, primarily engaged in the research, production, and sales of industrial aluminum processing products [3]. - The company has developed a diversified business model focusing on three core areas: industrial aluminum extrusion, deep processing, and aluminum rolling [3]. Historical Context - The company went public on May 8, 2009, and was recognized as the largest IPO globally following the 2008 financial crisis [2]. - In 2017, China Zhongwang made strategic acquisitions, including German high-end aluminum extrusion company Una Aluminum and Australian super yacht manufacturer Silver Yachts, to enhance its global presence [3]. Legal and Financial Challenges - In July 2019, China Zhongwang and several defendants were indicted by a grand jury in Los Angeles on 24 counts, leading to concerns about the company's operational and financial stability [4]. - The company faced significant operational difficulties, with its subsidiaries reporting severe financial losses and seeking bankruptcy restructuring in 2022 [5][6]. Restructuring Efforts - In September 2022, 14 subsidiaries of China Zhongwang filed for bankruptcy restructuring, with the court approving a substantial merger of 253 related companies to protect creditor rights [6]. - The deadline for submitting a restructuring plan was extended to June 20, 2023, indicating ongoing efforts to stabilize the company's financial situation [6]. Failed Listing Attempts - China Zhongwang attempted to spin off its subsidiary for a backdoor listing on the A-share market through China Real Estate Group but was unsuccessful in multiple attempts, leading to the eventual termination of these plans [7][8].

昔日"亚洲铝王"将退出港股市场，令人唏嘘。 博雷顿 分时图 日K线 周K线 月K线 28.45 10.45 58.06% 76.67% 51.11% 25.56% 0.00% 25.56% 51.11% 76.67% 4.20 8.80 13.40 18.00 22.60 27.20 31.80 09:30 10:30 12:00/13:00 14:00 16:10 1万 118万 235万 351万 4月6日晚，中国忠旺在港交所发布公告称，香港联交所宣布，由2023年4月13日上午9时起，该公司的上 市地位将被予以取消。 中国忠旺实控人刘忠田，贴有"亚洲铝王"标签，曾在2009年评为中国首富，2014年至2017年蝉联东北首 富。 昔日"亚洲铝王"折戟资本市场 中国忠旺于2009年5月登陆港股市场，募资近95亿港元，创造了当时自2008年金融危机以来全球融资规 模的新纪录。 中国忠旺主要从事多元化的优质工业铝加工产品的研发、生产及销售，形成了以工业铝挤压、深加工以 及铝压延三大核心业务并举的发展格局。公司产品广泛应用于绿色建造、交通运输、机械设备及电力工 程等领域，并推动其轻量化发展。公司曾是全球第二大、亚 ...

证券代码：600884 证券简称：杉杉股份（维权） 公告编号：临2025-039 登录新浪财经APP 搜索【信披】查看更多考评等级 宁波杉杉股份有限公司 关于2025年4月份提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示 ● 被担保人名称及是否为上市公司关联人： 上海杉杉锂电材料科技有限公司下属全资子公司上海杉杉新材料有限公司、云南杉杉新材料有限公司、 福建杉杉科技有限公司，为宁波杉杉股份有限公司（下称"公司"）合并报表范围内公司。本次担保不属 于关联担保。 ● 本次担保金额及已实际为其提供的担保金额：本次提供的担保金额为36,000万元人民币。本次担保 前，公司及下属子公司已实际为其提供的担保金额为525,500万元人民币。 ● 本次是否有反担保：无。 ● 对外担保逾期的累计数量：无。 ● 截至2025年3月31日，公司及公司控股子公司提供的对外担保金额已超过公司最近一期经审计归属于 上市公司股东的净资产的50%以上，本次被担保人上海杉杉新材料有限公司的资产负债率超过70%，敬 请投资者注意相关 ...

ST华闻（000793）公告，公司于2025年5月6日与海南联合资产管理有限公司和海南省国有资本运营有 限公司签署了重整投资协议。根据协议，两家产业投资人合计支付6.1亿元重整投资款，受让公司转增 股份5亿股，每股价格为1.22元。重整投资旨在恢复和改善公司持续经营能力。海南联合、海南国资运 营作为预重整产业投资人，承诺在华闻集团重整计划获得海南省海口市中级人民法院裁定批准后，全面 履行投资义务。临时管理人已收到海南联合支付的报名保证金3000万元，将在投资款支付时转化为等额 投资款。 ...

证券代码：002309 证券简称：*ST中利 江苏中利集团股份有限公司投资者关系活动记录表 编号：2025-003 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系 | □媒体采访 √业绩说明会 | | 活动类别 | □新闻发布会 □路演活动 | | | □现场参观 □其他 | | 参与单位名 | | | 称及人员姓 | 线上参与公司 2024 年度网上业绩说明会的全体投资者 | | 名 | | | 时间 | 2025 年 04 月 29 日 15：00-17：00 | | 地点 | 价值在线（https：//www.ir-online.cn/）网络互动 | | | 董事长：许加纳先生 副董事长：黄昶先生 | | 上市公司接 | | | | 总经理：郑晓洁女士 | | 待人员姓名 | 财务总监兼董事会秘书：廖嘉琦先生 | | | 独立董事：詹有义先生 | | | 1.公司提及"处于重整阶段"，现有债务规模及展期比例如 | | | 何？是否已有战略投资者明确注资意向？重整资金是否优先用于 | | | 恢复产能？ | | | 答：感谢您对公司的关注。公司重整计划已于 2024 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002053 证券简称：云南能投 公告编号：2025-065 关于全资子公司取得专利证书的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 云南能源投资股份有限公司 云南能源投资股份有限公司（以下简称"公司"）全资子公司会泽云能投新能源开发有限公司、红河云能 投新能源开发有限公司及云南省盐业有限公司近日取得国家知识产权局颁发的4项《实用新型专利证 书》和2项《外观设计专利证书》，具体情况如下： ■ 上述专利的获得不会对公司本年度财务状况、经营成果等产生重大影响，但有利于公司进一步完善知识 产权保护体系，发挥自主知识产权优势，促进技术创新，增强公司综合竞争力。敬请广大投资者谨慎决 策，注意投资风险。 特此公告。 关于向参股公司所提供的委托贷款逾期的进展公告 云南能源投资股份有限公司董事会 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 2025年4月30日 重要提示： 证券代码：002053证券简称：云南能投公告编号：2025-066 云南能源投资股 ...

Core Insights - In 2024, Chongqing Trust reported a total revenue of 500 million yuan, with a total profit of 258 million yuan and a net profit of 204 million yuan, of which 208 million yuan was attributable to the parent company [1] - The company is transitioning from a non-standard financing model to a diversified business model focused on asset services, asset management, and public welfare [1] Business Strategy - Chongqing Trust implemented a new strategy called "Fixed Income + Investment + Non-standard + Asset Management," focusing on innovative areas such as bankruptcy reorganization, QDII business, and green finance [1] - The company successfully engaged in bankruptcy reorganization, winning investment shares in 35 companies, including New Light Holdings, and established a reorganization service trust with a scale of 53.9 billion yuan [1] - Notable investment returns were achieved in the reorganization projects of Taihai Nuclear Power and Aorede, with investment yields of 28.57% and 90.12% respectively [1] Equity Investment - Chongqing Trust has expanded its equity investment offerings, including TOF, direct stock investments, and family service trust products, launching the first family service trust "Jufu No. 2" [2] - The company has collaborated with consumer finance companies to develop ABS business, with a cumulative scale reaching 9 billion yuan [2] Risk Management - In response to the real estate sector's risks, Chongqing Trust has implemented comprehensive risk management strategies, successfully mitigating over 7 billion yuan in risks since 2023 [2] - The company employs various methods for debt collection, including online communication, written reminders, and negotiations with local governments to ensure property sales and debt recovery [2] - Chongqing Trust actively seeks support from courts and local governments, utilizing legal measures such as freezing and auctioning to protect the rights of trustees [2]

Core Viewpoint - In April 2025, Hunan Jingfeng Pharmaceutical Co., Ltd. released its 2024 annual report, revealing significant changes in key financial indicators such as revenue, net profit, and cash flow, indicating potential operational challenges and risks for investors [1] Financial Performance Summary - **Revenue**: The company reported a revenue of 416,031,777.19 yuan in 2024, a decrease of 36.67% from 656,893,837.84 yuan in 2023. The pharmaceutical business accounted for 94.05% of total revenue, declining by 37.86% [2] - **Net Profit**: The net profit attributable to shareholders was 152,304,308.31 yuan, a turnaround from a loss of 236,100,444.69 yuan in 2023. However, the net profit excluding non-recurring items was -76,117,930.25 yuan, indicating weak core business profitability [3] - **Earnings Per Share**: Basic earnings per share improved to 0.1731 yuan from -0.2684 yuan in 2023, while the diluted earnings per share excluding non-recurring items was -0.0865 yuan, highlighting the disparity in earnings quality [4] Expense Analysis - **Sales Expenses**: Sales expenses decreased by 60.51% to 137,032,632.93 yuan from 347,051,196.83 yuan in 2023, potentially impacting market promotion and sales performance [5] - **Management Expenses**: Management expenses fell by 28.09% to 112,695,669.98 yuan, reflecting successful cost reduction measures [6] - **Financial Expenses**: Financial expenses remained stable at 40,282,025.19 yuan, indicating ongoing debt pressure, with a notable bond balance of 185 million yuan due [7] Cash Flow Analysis - **Operating Cash Flow**: The net cash flow from operating activities turned negative at -5,550,958.03 yuan, down 115.83% from 35,063,943.44 yuan in 2023, indicating weakened cash generation ability [10] - **Investing Cash Flow**: The net cash flow from investing activities was positive at 64,489,461.03 yuan, a recovery from -9,366,822.30 yuan in 2023, primarily due to asset disposals [11] - **Financing Cash Flow**: The net cash flow from financing activities improved to -10,724,112.52 yuan from -192,978,032.40 yuan in 2023, reflecting a need for improved financing conditions [12] Overall Assessment - Despite achieving a net profit turnaround, the company faces challenges with declining revenue, deteriorating cash flow, and reduced R&D investment, which may impact future growth potential. Investors should closely monitor the company's restructuring process, market strategy adjustments, and cost control efforts to assess investment value and risks [1]